Researched by Belong.Life and published by ASCO
examined the reasons behind the extremely low level (~3%) of clinical trial participation among cancer patients. Clinical trial participation is crucial for medical advancement and is an important treatment option, at times the only one, for oncology patients. This study highlights the importance for the oncological community to not only inform, but personally tailor clinical trial information to cancer patients and caregivers, and stresses how digital health platforms are an important source for driving awareness of clinical trials. This study highlights the importance for the oncological community to not only inform, but personally tailor clinical trial information to cancer patients and caregivers, and stresses how digital health platforms are an important source for driving awareness of clinical trials
